Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
Verified report from bloomberg.com
NewsMatic brief
Leo Pharma A/S is delaying plans for an initial public offering beyond 2026, pushing back a listing it had previously targeted for this year.
NewsMatic provides a concise source-linked brief. The protected full report and continuing updates remain with the original publisher.
Read the full report at bloomberg.com →